One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma
NCT02852343 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2018-09-11
Summary
The investigators main objective is to show that OSNA technique is as accurate as pathological analysis (frozen section / HE staining and immunochemistry) to detect occult lymph node metastasis (micro and macrometastasis).
Conditions
- cN0 Oral Squamous Cell Carcinomas
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-05
- Primary Completion
- 2016-12-21
- Completion
- 2016-12-21
Countries
- France
Study Locations
More Related Trials
-
Liquid Biopsy in Head and Neck Cancer
NCT03926468 ·Status: UNKNOWN
-
Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip
NCT06678724 ·Status: RECRUITING
-
Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)
NCT04464122 ·Status: RECRUITING
-
Contribution of Residual Tumour DNA Testing on the Surgical Bed
NCT05934929 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer
NCT00491621 ·Status: TERMINATED ·Phase: NA
-
Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
NCT00002695 ·Status: COMPLETED
-
Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination
NCT05935995 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
NCT00898664 ·Status: COMPLETED
-
Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
NCT05791149 ·Status: RECRUITING ·Phase: NA
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis
NCT03868215 ·Status: UNKNOWN
-
Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
NCT00318604 ·Status: UNKNOWN
-
Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
NCT06853730 ·Status: COMPLETED
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
NCT04490564 ·Status: COMPLETED
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
NCT05108090 ·Status: RECRUITING ·Phase: NA
-
A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
NCT02857608 ·Status: WITHDRAWN ·Phase: PHASE2
-
CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.
NCT02789384 ·Status: RECRUITING ·Phase: NA
-
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
NCT06420219 ·Status: RECRUITING
-
Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00898911 ·Status: COMPLETED
-
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
NCT01062438 ·Status: COMPLETED
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.
NCT04213664 ·Status: UNKNOWN
-
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT04099290 ·Status: RECRUITING
-
Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors
NCT06939049 ·Status: COMPLETED
-
Microbiome in Head and Neck Squamous Cell Carcinoma
NCT05837221 ·Status: RECRUITING